Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors
Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors have?
Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors has 50 citations in the OpenAlex counts ScholarIQ stores.
When was Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors published?
Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors has 2023 year in the ScholarIQ index.
What is the open-access status of Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors?
Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors has gold oa status in the ScholarIQ index.
What is the DOI of Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors?
The DOI for Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors is on the source record.
What is the PMID of Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors?
The PMID for Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors is on the source record.
What is the OpenAlex record for Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors?
The OpenAlex for Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors is on the source record.